 Connection
Adam Green to Humans
This is a "connection" page, showing publications Adam Green has written about Humans.
|
|
| |
Connection Strength |
|
 |
|
 |
| |
0.788 |
|
|
|
-
Daley W, Pacheco D, Miller CF, Walker D, Green AL. Creation and Effectiveness of a HeadSmart-Based Primary Provider Education Tool for Timely Pediatric CNS Tumor Diagnosis. J Cancer Educ. 2026 Jun; 41(3):576-580.
Score: 0.023
-
Green A, Patel S, Crabtree P, Patel D, Hoke A, Orozco RJ, Sangah G, Mercado A, Melchiorre N, Charron M, Chandel A, Puri N. The association of sepsis bundle compliance with mortality in patients with ICU-acquired sepsis: a cohort study. BMC Infect Dis. 2025 May 20; 25(1):723.
Score: 0.022
-
Green AL, Minard CG, Liu X, Safgren SL, Pinkney K, Harris L, Link G, DeSisto J, Voss S, Nelson MD, Reid JM, Fox E, Weigel BJ, Glade Bender J. Phase I Trial of Selinexor in Pediatric Recurrent/Refractory Solid and CNS Tumors (ADVL1414): A Children's Oncology Group Phase I Consortium Trial. Clin Cancer Res. 2025 May 01; 31(9):1587-1595.
Score: 0.022
-
DeSisto J, Balakrishnan I, Knox AJ, Link G, Venkataraman S, Vibhakar R, Green AL. PRMT5 Maintains Tumor Stem Cells to Promote Pediatric High-Grade Glioma Tumorigenesis. Mol Cancer Res. 2025 02 06; 23(2):107-118.
Score: 0.022
-
DeSisto J, Donson AM, Griesinger AM, Fu R, Riemondy K, Mulcahy Levy J, Siegenthaler JA, Foreman NK, Vibhakar R, Green AL. Tumor and immune cell types interact to produce heterogeneous phenotypes of pediatric high-grade glioma. Neuro Oncol. 2024 03 04; 26(3):538-552.
Score: 0.020
-
Collins A, Molina Kuna E, Anderson-Mellies A, Cost C, Green AL. Investigating the Impact of Tumor Biology and Social Determinants on Time to Diagnosis and Stage at Presentation of Wilms Tumor. J Pediatr Hematol Oncol. 2024 04 01; 46(3):147-153.
Score: 0.020
-
Chandel A, Fabyan KD, Mendelsohn S, Puri N, Damuth E, Rackley CR, Conrad SA, King CS, Green A. Prevalence and Survival of Prolonged Venovenous Extracorporeal Membrane Oxygenation for Acute Respiratory Distress Syndrome: An Analysis of the Extracorporeal Life Support Organization Registry. Crit Care Med. 2024 06 01; 52(6):869-877.
Score: 0.020
-
Lind KT, Molina E, Mellies A, Schneider KW, Daley W, Green AL. Early death from childhood cancer: First medical record-level analysis reveals insights on diagnostic timing and cause of death. Cancer Med. 2023 10; 12(19):20201-20211.
Score: 0.020
-
Green A, Rachoin JS, Schorr C, Dellinger P, Casey JD, Park I, Gupta S, Baron RM, Shaefi S, Hunter K, Leaf DE. Timing of invasive mechanical ventilation and death in critically ill adults with COVID-19: A multicenter cohort study. PLoS One. 2023; 18(6):e0285748.
Score: 0.020
-
Goulding D, Arguinchona L, Anderson-Mellies A, Mikkelsen M, Eguchi M, Marinoff H, Zahedi S, Ribeiro KB, Cockburn M, Rodriguez Galindo C, Green AL. Sociodemographic Disparities in Presentation and Survival of Pediatric Bone Cancers. J Pediatr Hematol Oncol. 2023 01 01; 45(1):e31-e43.
Score: 0.018
-
Greer HR, Miller K, Samay S, Nellan A, Green AL. Investigation of white blood cell characteristics in cerebrospinal fluid samples at pediatric brain tumor diagnosis. J Neurooncol. 2022 Sep; 159(2):301-308.
Score: 0.018
-
Hart M, Anderson-Mellies A, Beltrami A, Gilani A, Green AL. Population-based analysis of CNS tumor diagnoses, treatment, and survival in congenital and infant age groups. J Neurooncol. 2022 Apr; 157(2):333-344.
Score: 0.018
-
Lind KT, Chatwin HV, DeSisto J, Coleman P, Sanford B, Donson AM, Davies KD, Willard N, Ewing CA, Knox AJ, Mulcahy Levy JM, Gilani A, Green AL. Novel RAF Fusions in Pediatric Low-Grade Gliomas Demonstrate MAPK Pathway Activation. J Neuropathol Exp Neurol. 2021 12 29; 80(12):1099-1107.
Score: 0.018
-
Beltrami A, Hilliard A, Green AL. Demographic and socioeconomic disparities in pediatric cancer in the United States: Current knowledge, deepening understanding, and expanding intervention. Cancer Epidemiol. 2022 02; 76:102082.
Score: 0.018
-
DeSisto J, Lucas JT, Xu K, Donson A, Lin T, Sanford B, Wu G, Tran QT, Hedges D, Hsu CY, Armstrong GT, Arnold M, Bhatia S, Flannery P, Lemma R, Hardie L, Schüller U, Venkataraman S, Hoffman LM, Dorris K, Mulcahy Levy JM, Hankinson TC, Handler M, Liu AK, Foreman N, Vibhakar R, Jones K, Allen S, Zhang J, Baker SJ, Merchant TE, Orr BA, Green AL. Comprehensive molecular characterization of pediatric radiation-induced high-grade glioma. Nat Commun. 2021 09 20; 12(1):5531.
Score: 0.017
-
Darlington WS, Green AL. The role of geographic distance from a cancer center in survival and stage of AYA cancer diagnoses. Cancer. 2021 10 01; 127(19):3508-3510.
Score: 0.017
-
Chatwin HV, Cruz Cruz J, Green AL. Pediatric high-grade glioma: moving toward subtype-specific multimodal therapy. FEBS J. 2021 11; 288(21):6127-6141.
Score: 0.017
-
Norris GA, Tsai AC, Schneider KW, Wu YH, Caulfield T, Green AL. A novel, germline, deactivating CBL variant p.L493F alters domain orientation and is associated with multiple childhood cancers. Cancer Genet. 2021 06; 254-255:18-24.
Score: 0.016
-
Greer HR, Orbach DB, Yock TI, Rodriguez-Galindo C, Green AL. Intra-arterial chemotherapy for rhabdomyosarcoma. Pediatr Hematol Oncol. 2021 05; 38(4):391-396.
Score: 0.016
-
Faulk KE, Anderson-Mellies A, Cockburn M, Green AL. Assessment of enrollment characteristics for Children's Oncology Group (COG) upfront therapeutic clinical trials 2004-2015. PLoS One. 2020; 15(4):e0230824.
Score: 0.016
-
Fineberg R, Zahedi S, Eguchi M, Hart M, Cockburn M, Green AL. Population-Based Analysis of Demographic and Socioeconomic Disparities in Pediatric CNS Cancer Survival in the United States. Sci Rep. 2020 03 12; 10(1):4588.
Score: 0.016
-
Gilani A, Donson A, Davies KD, Whiteway SL, Lake J, DeSisto J, Hoffman L, Foreman NK, Kleinschmidt-DeMasters BK, Green AL. Targetable molecular alterations in congenital glioblastoma. J Neurooncol. 2020 Jan; 146(2):247-252.
Score: 0.015
-
DeSisto JA, Flannery P, Lemma R, Pathak A, Mestnik S, Philips N, Bales NJ, Kashyap T, Moroze E, Venkataraman S, Kung AL, Carter BD, Landesman Y, Vibhakar R, Green AL. Exportin 1 Inhibition Induces Nerve Growth Factor Receptor Expression to Inhibit the NF-?B Pathway in Preclinical Models of Pediatric High-Grade Glioma. Mol Cancer Ther. 2020 02; 19(2):540-551.
Score: 0.015
-
Colton MD, Goulding D, Beltrami A, Cost C, Franklin A, Cockburn MG, Green AL. A U.S. population-based study of insurance disparities in cancer survival among adolescents and young adults. Cancer Med. 2019 08; 8(10):4867-4874.
Score: 0.015
-
Norris GA, Garcia J, Hankinson TC, Handler M, Foreman N, Mirsky D, Stence N, Dorris K, Green AL. Diagnostic accuracy of neuroimaging in pediatric optic chiasm/sellar/suprasellar tumors. Pediatr Blood Cancer. 2019 06; 66(6):e27680.
Score: 0.014
-
Colton MD, Hawkins M, Goulding D, Cockburn M, Green AL. Socioeconomics, race, and ethnicity in childhood cancer survival: Accessing and addressing root causes of disparities. Cancer. 2018 10 15; 124(20):3975-3978.
Score: 0.014
-
Flannery PC, DeSisto JA, Amani V, Venkataraman S, Lemma RT, Prince EW, Donson A, Moroze EE, Hoffman L, Levy JMM, Foreman N, Vibhakar R, Green AL. Preclinical analysis of MTOR complex 1/2 inhibition in diffuse intrinsic pontine glioma. Oncol Rep. 2018 Feb; 39(2):455-464.
Score: 0.013
-
McEvoy M, Robison N, Manley P, Yock T, Konopka K, Brown RE, Wolff J, Green AL. Successful Treatment of Recurrent Li-Fraumeni Syndrome-related Choroid Plexus Carcinoma. J Pediatr Hematol Oncol. 2017 11; 39(8):e473-e475.
Score: 0.013
-
Green AL, Mulcahy Levy JM, Vibhakar R, Hemenway M, Madden J, Foreman N, Dorris K. Tumor treating fields in pediatric high-grade glioma. Childs Nerv Syst. 2017 Jul; 33(7):1043-1045.
Score: 0.013
-
Green AL, Furutani E, Ribeiro KB, Rodriguez Galindo C. Death Within 1 Month of Diagnosis in Childhood Cancer: An Analysis of Risk Factors and Scope of the Problem. J Clin Oncol. 2017 Apr 20; 35(12):1320-1327.
Score: 0.013
-
Green AL, Chintagumpala M, Krailo M, Langholz B, Albert D, Eagle R, Cockburn M, Chevez-Barrios P, Rodriguez-Galindo C. Correlation of Insurance, Race, and Ethnicity with Pathologic Risk in a Controlled Retinoblastoma Cohort: A Children's Oncology Group Study. Ophthalmology. 2016 08; 123(8):1817-1823.
Score: 0.012
-
Green AL, Yi J, Bezler N, Pikman Y, Tubman VN, Obeng EA, O'Neil T, Mersereau R, Morrissey L, Billett AL. A Prospective Cohort Quality Improvement Study to Reduce the Time to Antibiotics for New Fever in Neutropenic Pediatric Oncology Inpatients. Pediatr Blood Cancer. 2016 Jan; 63(1):112-7.
Score: 0.011
-
Green AL, Kieran MW. Pediatric brainstem gliomas: new understanding leads to potential new treatments for two very different tumors. Curr Oncol Rep. 2015 Mar; 17(3):436.
Score: 0.011
-
Green AL, Ramkissoon SH, McCauley D, Jones K, Perry JA, Hsu JH, Ramkissoon LA, Maire CL, Hubbell-Engler B, Knoff DS, Shacham S, Ligon KL, Kung AL. Preclinical antitumor efficacy of selective exportin 1 inhibitors in glioblastoma. Neuro Oncol. 2015 May; 17(5):697-707.
Score: 0.011
-
Green AL, Srivatsa A, Rodriguez-Galindo C. Delayed diagnosis and false relapse due to paternal testosterone use in adrenocortical carcinoma. Pediatrics. 2014 Jun; 133(6):e1772-6.
Score: 0.010
-
Sidpra J, Lind V, Cohen AL, Schaper FLWVJ, Stone TJ, Grabovska Y, Biswas A, Sudhakar S, Sepulveda F, Peres BS, Veronese G, Alemán-Charlet C, Ogunbiyi O, Shamardani K, Zhao J, Palacin AC, Miller G, Opipari RS, De Vita E, Ridout D, Ferraciolli SF, Lucato LT, Avsenik J, Piccirilli E, Morales-La Madrid A, Muchart J, Ryan ME, Patel R, Haldipur P, Hill CS, Krüger MT, Zrinzo L, Jeelani NUO, Martinez-Barbera JP, Donson AM, Dorris K, Morgan PS, Mackay A, Venkatesh HS, Horn A, Mueller S, Green AL, Mirsky DM, Akram H, Jones C, Aquilina K, Mankad K, Monje M, Jacques TS, Fox MD, Hargrave DR. A prognostic human brain network for diffuse midline glioma. Nature. 2026 Jul; 655(8123):769-779.
Score: 0.006
-
Crowell C, Mankuzhy NP, Bennett J, Bandopadhayay P, Sturm D, Green AL, Gupta T, Chatterjee A, Epari S, Chinnaswamy G, Prasad M, Patel SH, MacNeil M, Vanan MI, Larouche V, Renzi S, Jones J, Perreault S, Mata-Mbemba D, Sangatsuda Y, Yoshimoto K, Lin E, Feddersen C, Cruz O, Pavon-Mengual M, Vizzini O, Zápotocký M, Popovacki A, Klawinski D, Hansford JR, Schlosser MP, Omene E, Alexander KL, Satgunaseelan L, Williams A, Yao K, Ronsley R, Cheng S, Ludlow L, Eisenstat D, Khuong-Quang DA, Tabouret E, André N, Matheson K, Chan A, Lim-Fat MJ, Lapointe S, Cayrol R, Coleman C, Juretic N, McThenia S, Khan S, Wright-Nadkarni M, Salloum R, Galvin RT, Sener U, Hawkins C, Imber BS, Karajannis MA, Jones DTW, Ligon KL, Jabado N, Erker C. Clinical Outcomes and Prognostic Features of Diffuse Hemispheric Glioma, H3 G34-Mutant: An International Multi-institutional Study. Clin Cancer Res. 2026 Jun 01; 32(11):2243-2254.
Score: 0.006
-
Keane L, ?kandík M, Posada-Pérez M, Bose R, Desito J, van der Linde E, Engskog-Vlachos P, Ceccatelli S, Green AL, Joseph B. Microglia in diffuse midline glioma contribute to extracellular matrix remodelling and cancer cell invasion. Cell Death Dis. 2026 May 30; 17(1).
Score: 0.006
-
Leaf DE, Monson AE, Dias JA, Marcos LA, Wu U, Rossi M, Ng JH, Patell R, Hundert J, El Khoury MY, Higgs J, Smith RP, Ramsaroop V, Green A, Abdul Azim A, Weisenberg S, Kirkman LA, Ingram D, Hsu CM, Dieckhaus K, Hyson P, Burger Z, Chengsupanimit T, Stalmack T, Aber R, Golden M, Koshy M, Wright K, Cortezzo G, McLeod G, Wenzel-Rideout R, Baigorri JJ, Bagchi A, Jaser A, Socorro Matos G, Sanchez-Almanzar D, Hoge ST, Shenoy T, Krishnamurthy S, Kaunfer SA, Blau JA, Woolley A, Zamor R, Maczaj B, Kenison D, Totten A, Bateman V, Mohsin S, Lee ES, Garner J, Rath P, Wu Q, Guermazi D, London A, Arvanitis P, Yune PS, Abdullah M, Kim A, Roy J, George R, Kashfi S, Hong S, Upadrista P, Hirsch JS, Bulteel A, Sharma R, Guo T, Garcia D, Shaefi S, Yeb J, Williams G, Verma E, Gouda N, Rosenthal HR, Chan A, Zainah H, Heithaus S, Saldivar MA, Wood E, DiPalazzo J, Elias S, McAuliffe M, Abbas R, Orenstein A, Tidswell MA, Galiano P, Spencer S, Srinivasan S, Xu J, Alla S, Alidoost L, Jacobson E, Menghani SV, Kannabran P, Ogunribido DB, Ssentongo P, Powell D, Meyer L, Prabhune K, Griffiths B, Gonzalez Aponte D, Dixon G, Vannier E, Roberts SC, Farmakiotis D, Krause PJ. Red Blood Cell Exchange Transfusion for Severe Babesiosis. JAMA Intern Med. 2026 May 01; 186(5):597-607.
Score: 0.006
-
Tomita Y, Link G, Ge Y, Gold ERH, Racanelli A, Cardona HJ, Romero M, Gadd S, Watanabe J, Uchida E, Hashizume R, Takata N, Pinero G, Hambardzumyan D, Spasojevic I, Hu G, Hennika T, Brat DJ, Green AL, Becher OJ. Effects of combination therapy of a CDK4/6 and MEK inhibitor in diffuse midline glioma preclinical models. PLoS One. 2025; 20(12):e0323235.
Score: 0.006
-
Oddy C, Lowcock D, Davies TW, Towey S, Burnett M, Davis A, Davey G, Green A, Bools O, Coulton M, Lewith H, Perella P, Wong DJN. Structural and organisational impacts of peri-operative enhanced care services in the UK: a Retrospective Evaluation of Postoperative Alternatives to Critical Care (REPACC). Anaesthesia. 2026 Apr; 81(4):500-512.
Score: 0.006
-
Miller CEF, Luehring JN, Kuna EBM, Bhatia S, Green AL, Compas BE. Shared Sociodemographic Risk Factors for Neurocognitive Dysfunction in Children With Cancer and Blood Disorders. Pediatr Blood Cancer. 2026 01; 73(1):e32131.
Score: 0.006
-
Balakrishnan I, Madhavan K, Pierce A, Michlin J, Brunt B, Lakshmanachetty S, Wang D, DeSisto J, Nuss ZJ, Davidson N, Walker F, Suresh A, Donson A, Sanford B, Jones KL, Danis EP, Mitra SS, Green AL, Dahl N, Vibhakar R, Venkataraman S. Development of an Anti-CD99 Antibody Enables Targeting of Diffuse Midline Glioma. Cancer Res. 2025 08 15; 85(16):3089-3110.
Score: 0.006
-
Zahedi S, Riemondy K, Liu T, Griesinger AM, Donson AM, Apfelbaum AA, Fu R, Grandvallet Contreras J, Crespo M, DeSisto J, Groat MM, Bratbak E, Green A, Hankinson TC, Handler M, Vibhakar R, Willard N, Foreman NK, Phang T, Mulcahy Levy J. Multi-pronged analysis of pediatric low-grade glioma and ganglioglioma reveals a unique tumor microenvironment associated with BRAF alterations. Brain Pathol. 2025 Nov; 35(6):e70023.
Score: 0.006
-
Feinman GM, Cervantes Quequezana G, Green A, Lawrence D, Munson J, Ortman S, Petrie C, Thompson A, Nicholas LM. Assessing grand narratives of economic inequality across time. Proc Natl Acad Sci U S A. 2025 Apr 22; 122(16):e2400698121.
Score: 0.006
-
Kohler TA, Bogaard A, Ortman SG, Crema ER, Chirikure S, Cruz P, Green A, Kerig T, McCoy MD, Munson J, Petrie C, Thompson AE, Birch J, Cervantes Quequezana G, Feinman GM, Fochesato M, Gronenborn D, Hamerow H, Jin G, Lawrence D, Roscoe PB, Rosenstock E, Erny GK, Kim H, Ohlrau R, Hanson JW, Fargher Navarro L, Pailes M. Economic inequality is fueled by population scale, land-limited production, and settlement hierarchies across the archaeological record. Proc Natl Acad Sci U S A. 2025 Apr 22; 122(16):e2400691122.
Score: 0.006
-
Damuth E, Baldwin C, Schmalbach N, Green A, Puri N, Jones CW. Sex Disparity in Extracorporeal Membrane Oxygenation Clinical Trial Enrollment. Crit Care Med. 2025 Feb 01; 53(2):e424-e428.
Score: 0.005
-
Bryan G, Guolla L, Villanueva GI, Cohen-Gogo S, Casanovas A, Medina R, Revon-Riviere G, Coltin H, Kahalley LS, Withycombe JS, van Ewijk R, Schoot RA, Cash T, Baertschiger RM, McAleer MF, Benedetti DJ, Greengard E, Kitko CL, Green AL, Dhall G, Esbenshade AJ. Impact of the COVID-19 Pandemic Onset on the Early Careers of Pediatric Oncology Health Professionals and Researchers: A Report From the Children's Oncology Group Young Investigators Committee, Young SIOP Network, and Young SIOPE. Pediatr Blood Cancer. 2025 Jan; 72(1):e31419.
Score: 0.005
-
Ross JL, Puigdelloses-Vallcorba M, Piñero G, Soni N, Thomason W, DeSisto J, Angione A, Tsankova NM, Castro MG, Schniederjan M, Wadhwani NR, Raju GP, Morgenstern P, Becher OJ, Green AL, Tsankov AM, Hambardzumyan D. Microglia and monocyte-derived macrophages drive progression of pediatric high-grade gliomas and are transcriptionally shaped by histone mutations. Immunity. 2024 11 12; 57(11):2669-2687.e6.
Score: 0.005
-
Ou JY, Kaddas HK, Alonzo TA, Spector LG, Fallahazad N, Owens E, Collin LJ, Green AL, Kirchhoff AC. Sociodemographic and Socioeconomic Factors Correlate with Late-Stage Pediatric Hodgkin Lymphoma and Rhabdomyosarcoma: A Report from the Children's Oncology Group Registries. Cancer Epidemiol Biomarkers Prev. 2024 Oct 02; 33(10):1327-1338.
Score: 0.005
-
Andrea L, Herman NS, Vine J, Berg KM, Choudhury S, Vaena M, Nogle JE, Halablab SM, Kaviyarasu A, Elmer J, Wardi G, Pearce AK, Crowley C, Long MT, Herbert JT, Shipley K, Bissell Turpin BD, Lanspa MJ, Green A, Ghamande SA, Khan A, Dugar S, Joffe AM, Baram M, March C, Johnson NJ, Reyes A, Denchev K, Loewe M, Moskowitz A. The Discover In-Hospital Cardiac Arrest (Discover IHCA) Study: An Investigation of Hospital Practices After In-Hospital Cardiac Arrest. Crit Care Explor. 2024 09 01; 6(9):e1149.
Score: 0.005
-
Martinez PJ, Green AL, Borden MA. Targeting diffuse midline gliomas: The promise of focused ultrasound-mediated blood-brain barrier opening. J Control Release. 2024 01; 365:412-421.
Score: 0.005
-
van Thiel Berghuijs KM, Kaddas HK, Warner EL, Fair DB, Fluchel M, Knackstedt ED, Verma A, Kepka D, Green AL, Smitherman AB, Draper L, Johnson RH, Kirchhoff AC. Vaccination practices of pediatric oncologists from eight states. BMC Health Serv Res. 2023 Nov 07; 23(1):1215.
Score: 0.005
-
Roberts HJ, Ji S, Picca A, Sanson M, Garcia M, Snuderl M, Schüller U, Picart T, Ducray F, Green AL, Nakano Y, Sturm D, Abdullaev Z, Aldape K, Dang D, Kumar-Sinha C, Wu YM, Robinson D, Vo JN, Chinnaiyan AM, Cartaxo R, Upadhyaya SA, Mody R, Chiang J, Baker S, Solomon D, Venneti S, Pratt D, Waszak SM, Koschmann C. Clinical, genomic, and epigenomic analyses of H3K27M-mutant diffuse midline glioma long-term survivors reveal a distinct group of tumors with MAPK pathway alterations. Acta Neuropathol. 2023 12; 146(6):849-852.
Score: 0.005
-
Okonechnikov K, Joshi P, Sepp M, Leiss K, Sarropoulos I, Murat F, Sill M, Beck P, Chan KC, Korshunov A, Sah F, Deng MY, Sturm D, DeSisto J, Donson AM, Foreman NK, Green AL, Robinson G, Orr BA, Gao Q, Darrow E, Hadley JL, Northcott PA, Gojo J, Kawauchi D, Hovestadt V, Filbin MG, von Deimling A, Zuckermann M, Pajtler KW, Kool M, Jones DTW, Jäger N, Kutscher LM, Kaessmann H, Pfister SM. Mapping pediatric brain tumors to their origins in the developing cerebellum. Neuro Oncol. 2023 10 03; 25(10):1895-1909.
Score: 0.005
-
Hu XL, Xiao W, Lei Y, Green A, Lee X, Maradana MR, Gao Y, Xie X, Wang R, Chennell G, Basson MA, Kille P, Maret W, Bewick GA, Zhou Y, Hogstrand C. Aryl hydrocarbon receptor utilises cellular zinc signals to maintain the gut epithelial barrier. Nat Commun. 2023 09 05; 14(1):5431.
Score: 0.005
-
Johann PD, Altendorf L, Efremova EM, Holsten T, Steinbügl M, Nemes K, Eckhardt A, Kresbach C, Bockmayr M, Koch A, Haberler C, Antonelli M, DeSisto J, Schuhmann MU, Hauser P, Siebert R, Bens S, Kool M, Green AL, Hasselblatt M, Frühwald MC, Schüller U. Recurrent atypical teratoid/rhabdoid tumors (AT/RT) reveal discrete features of progression on histology, epigenetics, copy number profiling, and transcriptomics. Acta Neuropathol. 2023 09; 146(3):527-541.
Score: 0.005
-
Esbenshade AJ, Kahalley LS, Wistinghausen B, Cash T, Baertschiger RM, Zarnegar-Lumley S, Green A, Dhall G. Children's Oncology Group's 2023 blueprint for research: Young investigators. Pediatr Blood Cancer. 2023 09; 70 Suppl 6:e30567.
Score: 0.005
-
Berkman AM, Andersen CR, Hildebrandt MAT, Livingston JA, Green AL, Puthenpura V, Peterson SK, Milam J, Miller KA, Freyer DR, Roth ME. Risk of early death in adolescents and young adults with cancer: a population-based study. J Natl Cancer Inst. 2023 04 11; 115(4):447-455.
Score: 0.005
-
Fraley CE, Neiman JS, Feddersen CR, James C, Jones TG, Mikkelsen M, Nuss R, Schlenz AM, Winters AC, Green AL, Compas BE. Identifying patterns of neurocognitive dysfunction through direct comparison of children with leukemia, central nervous system tumors, and sickle cell disease. Pediatr Blood Cancer. 2023 06; 70(6):e30299.
Score: 0.005
-
Ahmad Q, Green A, Chandel A, King C, Puri N. Prolonged Noninvasive Respiratory Support Before Intubation Leads to Increased Duration of ECMO: More Evidence That Less Is More. ASAIO J. 2023 06 01; 69(6):e286.
Score: 0.005
-
Ahmad Q, Chandel A, Green A, King C, Puri N. Duration of Noninvasive Respiratory Support and Extracorporeal Membrane Oxygenation Outcomes: Connecting the Dots. ASAIO J. 2023 02 01; 69(2):e113.
Score: 0.005
-
Ahmad Q, Green A, Chandel A, Lantry J, Desai M, Simou J, Osborn E, Singh R, Puri N, Moran P, Dalton H, Speir A, King C. Impact of Noninvasive Respiratory Support in Patients With COVID-19 Requiring V-V ECMO. ASAIO J. 2022 02 01; 68(2):171-177.
Score: 0.004
-
Lassman AB, Wen PY, van den Bent MJ, Plotkin SR, Walenkamp AME, Green AL, Li K, Walker CJ, Chang H, Tamir S, Henegar L, Shen Y, Alvarez MJ, Califano A, Landesman Y, Kauffman MG, Shacham S, Mau-Sørensen M. A Phase II Study of the Efficacy and Safety of Oral Selinexor in Recurrent Glioblastoma. Clin Cancer Res. 2022 02 01; 28(3):452-460.
Score: 0.004
-
Lencz T, Backenroth D, Granot-Hershkovitz E, Green A, Gettler K, Cho JH, Weissbrod O, Zuk O, Carmi S. Utility of polygenic embryo screening for disease depends on the selection strategy. Elife. 2021 10 12; 10.
Score: 0.004
-
Deng MY, Sturm D, Pfaff E, Sill M, Stichel D, Balasubramanian GP, Tippelt S, Kramm C, Donson AM, Green AL, Jones C, Schittenhelm J, Ebinger M, Schuhmann MU, Jones BC, van Tilburg CM, Wittmann A, Golanov A, Ryzhova M, Ecker J, Milde T, Witt O, Sahm F, Reuss D, Sumerauer D, Zamecnik J, Korshunov A, von Deimling A, Pfister SM, Jones DTW. Radiation-induced gliomas represent H3-/IDH-wild type pediatric gliomas with recurrent PDGFRA amplification and loss of CDKN2A/B. Nat Commun. 2021 09 20; 12(1):5530.
Score: 0.004
-
Schreck KC, Morin A, Zhao G, Allen AN, Flannery P, Glantz M, Green AL, Jones C, Jones KL, Kilburn LB, Nazemi KJ, Samuel D, Sanford B, Solomon DA, Wang J, Pratilas CA, Nicolaides T, Mulcahy Levy JM. Deconvoluting Mechanisms of Acquired Resistance to RAF Inhibitors in BRAFV600E-Mutant Human Glioma. Clin Cancer Res. 2021 11 15; 27(22):6197-6208.
Score: 0.004
-
Al-Samkari H, Gupta S, Leaf RK, Wang W, Rosovsky RP, Brenner SK, Hayek SS, Berlin H, Kapoor R, Shaefi S, Melamed ML, Sutherland A, Radbel J, Green A, Garibaldi BT, Srivastava A, Leonberg-Yoo A, Shehata AM, Flythe JE, Rashidi A, Goyal N, Chan L, Mathews KS, Hedayati SS, Dy R, Toth-Manikowski SM, Zhang J, Mallappallil M, Redfern RE, Bansal AD, Short SAP, Vangel MG, Admon AJ, Semler MW, Bauer KA, Hernán MA, Leaf DE. Thrombosis, Bleeding, and the Observational Effect of Early Therapeutic Anticoagulation on Survival in Critically Ill Patients With COVID-19. Ann Intern Med. 2021 05; 174(5):622-632.
Score: 0.004
-
Whiteway SL, Betts AM, O'Neil ER, Green AL, Gilani A, Orr BA, Mathis DA. Oncogenic GOPC-ROS1 Fusion Identified in a Congenital Glioblastoma Case. J Pediatr Hematol Oncol. 2020 11; 42(8):e813-e818.
Score: 0.004
-
Balakrishnan I, Danis E, Pierce A, Madhavan K, Wang D, Dahl N, Sanford B, Birks DK, Davidson N, Metselaar DS, Meel MH, Lemma R, Donson A, Vijmasi T, Katagi H, Sola I, Fosmire S, Alimova I, Steiner J, Gilani A, Hulleman E, Serkova NJ, Hashizume R, Hawkins C, Carcaboso AM, Gupta N, Monje M, Jabado N, Jones K, Foreman N, Green A, Vibhakar R, Venkataraman S. Senescence Induced by BMI1 Inhibition Is a Therapeutic Vulnerability in H3K27M-Mutant DIPG. Cell Rep. 2020 10 20; 33(3):108286.
Score: 0.004
-
Bhatia S, Bukkapatnam S, Van Court B, Phan A, Oweida A, Gadwa J, Mueller AC, Piper M, Darragh L, Nguyen D, Gilani A, Knitz M, Bickett T, Green A, Venkataraman S, Vibhakar R, Cittelly D, Karam SD. The effects of ephrinB2 signaling on proliferation and invasion in glioblastoma multiforme. Mol Carcinog. 2020 09; 59(9):1064-1075.
Score: 0.004
-
Dahl NA, Danis E, Balakrishnan I, Wang D, Pierce A, Walker FM, Gilani A, Serkova NJ, Madhavan K, Fosmire S, Green AL, Foreman NK, Venkataraman S, Vibhakar R. Super Elongation Complex as a Targetable Dependency in Diffuse Midline Glioma. Cell Rep. 2020 04 07; 31(1):107485.
Score: 0.004
-
Moreira DC, Venkataraman S, Subramanian A, Desisto J, Balakrishnan I, Prince E, Pierce A, Griesinger A, Green A, Eberhardt CG, Foreman NK, Vibhakar R. Targeting MYC-driven replication stress in medulloblastoma with AZD1775 and gemcitabine. J Neurooncol. 2020 May; 147(3):531-545.
Score: 0.004
-
Lake JA, Donson AM, Prince E, Davies KD, Nellan A, Green AL, Mulcahy Levy J, Dorris K, Vibhakar R, Hankinson TC, Foreman NK, Ewalt MD, Kleinschmidt-DeMasters BK, Hoffman LM, Gilani A. Targeted fusion analysis can aid in the classification and treatment of pediatric glioma, ependymoma, and glioneuronal tumors. Pediatr Blood Cancer. 2020 01; 67(1):e28028.
Score: 0.004
-
Zahedi S, Fitzwalter BE, Morin A, Grob S, Desmarais M, Nellan A, Green AL, Vibhakar R, Hankinson TC, Foreman NK, Mulcahy Levy JM. Effect of early-stage autophagy inhibition in BRAFV600E autophagy-dependent brain tumor cells. Cell Death Dis. 2019 09 12; 10(9):679.
Score: 0.004
-
Marini BL, Benitez LL, Zureick AH, Salloum R, Gauthier AC, Brown J, Wu YM, Robinson DR, Kumar C, Lonigro R, Vats P, Cao X, Kasaian K, Anderson B, Mullan B, Chandler B, Linzey JR, Camelo-Piragua SI, Venneti S, McKeever PE, McFadden KA, Lieberman AP, Brown N, Shao L, Leonard MAS, Junck L, McKean E, Maher CO, Garton HJL, Muraszko KM, Hervey-Jumper S, Mulcahy-Levy JM, Green A, Hoffman LM, Dorris K, Vitanza NA, Wang J, Schwartz J, Lulla R, Smiley NP, Bornhorst M, Haas-Kogan DA, Robertson PL, Chinnaiyan AM, Mody R, Koschmann C. Blood-brain barrier-adapted precision medicine therapy for pediatric brain tumors. Transl Res. 2017 10; 188:27.e1-27.e14.
Score: 0.003
-
Mulcahy Levy JM, Zahedi S, Griesinger AM, Morin A, Davies KD, Aisner DL, Kleinschmidt-DeMasters BK, Fitzwalter BE, Goodall ML, Thorburn J, Amani V, Donson AM, Birks DK, Mirsky DM, Hankinson TC, Handler MH, Green AL, Vibhakar R, Foreman NK, Thorburn A. Autophagy inhibition overcomes multiple mechanisms of resistance to BRAF inhibition in brain tumors. Elife. 2017 01 17; 6.
Score: 0.003
-
Truong B, Green AL, Friedrich P, Ribeiro KB, Rodriguez-Galindo C. Ethnic, Racial, and Socioeconomic Disparities in Retinoblastoma. JAMA Pediatr. 2015 Dec; 169(12):1096-104.
Score: 0.003
-
Hankinson TC, Patibandla MR, Green A, Hemenway M, Foreman N, Handler M, Liu AK. Hypofractionated Radiotherapy for Children With Diffuse Intrinsic Pontine Gliomas. Pediatr Blood Cancer. 2016 Apr; 63(4):716-8.
Score: 0.003
-
Ross SG, Northman L, Morris M, Green AL, Ullrich NJ. Cerebellar mutism after posterior fossa tumor resection: case discussion and recommendations for psychoeducational intervention. J Pediatr Oncol Nurs. 2014 Mar-Apr; 31(2):78-83.
Score: 0.003
-
Gardner SL, Asgharzadeh S, Green A, Horn B, McCowage G, Finlay J. Intensive induction chemotherapy followed by high dose chemotherapy with autologous hematopoietic progenitor cell rescue in young children newly diagnosed with central nervous system atypical teratoid rhabdoid tumors. Pediatr Blood Cancer. 2008 Aug; 51(2):235-40.
Score: 0.002
|
Connection Strength
The connection strength for concepts is the sum of the scores for each matching publication.
Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.
|